UBS has reaffirmed its 'buy' recommendation and price target of 7170 pence (representing a 62% upside potential for the stock) on Reckitt Benckiser, anticipating 'sequentially better operating momentum in the first quarter'.

The broker expects the British group to post stable like-for-like sales growth in the first quarter, with growth of nearly 3% in hygiene and health, offset by a 14% decline in nutrition.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.